Dr. Riggs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1021 Morehead Medical Dr
Ste 6100
Charlotte, NC 28204Phone+1 980-442-2000Fax+1 980-442-6131
Summary
- Dr. Stephen Riggs is a Urologic Oncologist in Charlotte, NC and is affiliated with multiple hospitals in the area, including Atrium Health's Carolinas Medical Center. He received his medical degree from Medical University of South Carolina College of Medicine and has been in practice 16 years. He specializes in surgical oncology and is experienced in prostate cancer, urologic oncology, testicular cancer, and urinary tract cancer (bladder and kidney).
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Urologic Surgical Oncology, 2006 - 2008
University of Mississippi Medical CenterResidency, Urology, 2003 - 2006- University of Mississippi Medical CenterResidency, Surgery, 2001 - 2003
Medical University of South CarolinaClass of 2001
Certifications & Licensure
CA State Medical License 2006 - Present
NC State Medical License 2012 - 2025
VA State Medical License 2008 - 2014- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Start of enrollment: 2007 Sep 01
Publications & Presentations
PubMed
- 1 citationsInterruptions in bladder cancer care during the COVID-19 public health emergency.John L Gore, Kristin Follmer, Jason Reynolds, Michael Nash, Christopher B Anderson
Urologic Oncology. 2024-04-01 - 10 citationsSafety of decreasing ureteral stent duration following radical cystectomy.Hamza Beano, Jiaxian He, Caitlin Hensel, William M. Worrilow, William Blair Townsend
World Journal of Urology. 2021-02-01 - 141 citationsHypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.Tobias Klatte, David Seligson, Stephen B. Riggs, John T. Leppert, Maria K. Berkman
Clinical Cancer Research. 2007-12-15
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
